Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Sponge-supported cultures of primary head and neck tumors for an optimized preclinical model.

Dohmen AJC, Sanders J, Canisius S, Jordanova ES, Aalbersberg EA, van den Brekel MWM, Neefjes J, Zuur CL.

Oncotarget. 2018 May 18;9(38):25034-25047. doi: 10.18632/oncotarget.25244. eCollection 2018 May 18.

3.

Sponge-gel-supported histoculture drug-response assay for head and neck cancer. Correlations with clinical response to cisplatin.

Robbins KT, Connors KM, Storniolo AM, Hanchett C, Hoffman RM.

Arch Otolaryngol Head Neck Surg. 1994 Mar;120(3):288-92.

PMID:
8123238
4.

Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway Activation.

Singh M, Close DA, Mukundan S, Johnston PA, Sant S.

Assay Drug Dev Technol. 2015 Nov;13(9):570-83. doi: 10.1089/adt.2015.662. Epub 2015 Aug 14.

5.

Human-in-mouse modeling of primary head and neck squamous cell carcinoma.

Law JH, Whigham AS, Wirth PS, Liu D, Pham MQ, Vadivelu S, Kirkbride KC, Brown BT, Burkey BB, Sinard RJ, Netterville JL, Yarbrough WG.

Laryngoscope. 2009 Dec;119(12):2315-23. doi: 10.1002/lary.20607.

PMID:
19693929
6.

3D Sponge-Matrix Histoculture: An Overview.

Hoffman RM.

Methods Mol Biol. 2018;1760:11-17. doi: 10.1007/978-1-4939-7745-1_2. Review.

PMID:
29572789
7.
8.

[The effect of the microenvironment of head and neck cancers on tumor progression].

Lukits J.

Magy Onkol. 2009 Mar;53(1):51-9. doi: 10.1556/MOnkol.53.2009.1.8. Hungarian.

9.

Retinoic acid modulates the radiosensitivity of head-and-neck squamous carcinoma cells grown in collagen gel.

Rossi L, Corvò R.

Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1319-27.

PMID:
12128135
10.

Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.

Saloura V, Fatima A, Zewde M, Kiyotani K, Brisson R, Park JH, Ikeda Y, Vougiouklakis T, Bao R, Khattri A, Seiwert T, Cipriani N, Lingen M, Vokes E, Nakamura Y.

Clin Cancer Res. 2017 Aug 15;23(16):4897-4907. doi: 10.1158/1078-0432.CCR-17-0103. Epub 2017 Apr 25.

11.

Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma.

Zhang ZP, Sun YL, Fu L, Gu F, Zhang L, Hao XS.

Ai Zheng. 2009 Feb;28(2):100-3. Epub 2009 Feb 23.

PMID:
19550121
13.

p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.

Shin DM, Lee JS, Lippman SM, Lee JJ, Tu ZN, Choi G, Heyne K, Shin HJ, Ro JY, Goepfert H, Hong WK, Hittelman WN.

J Natl Cancer Inst. 1996 Apr 17;88(8):519-29.

PMID:
8606380
14.

Drug response of head and neck tumors in native-state histoculture.

Robbins KT, Varki NM, Storniolo AM, Hoffman H, Hoffman RM.

Arch Otolaryngol Head Neck Surg. 1991 Jan;117(1):83-6.

PMID:
1986767
15.

Prostaglandin E1 and misoprostol increase epidermal growth factor production in 3D-cultured human annulus cells.

Gruber HE, Hoelscher G, Loeffler B, Chow Y, Ingram JA, Halligan W, Hanley EN Jr.

Spine J. 2009 Sep;9(9):760-6. doi: 10.1016/j.spinee.2009.04.024. Epub 2009 Jun 16.

PMID:
19535298
16.
17.

Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.

Sirianni N, Ha PK, Oelke M, Califano J, Gooding W, Westra W, Whiteside TL, Koch WM, Schneck JP, DeLeo A, Ferris RL.

Clin Cancer Res. 2004 Oct 15;10(20):6929-37.

18.

Prediction of survival in patients with head and neck cancer using the histoculture drug response assay.

Singh B, Li R, Xu L, Poluri A, Patel S, Shaha AR, Pfister D, Sherman E, Goberdhan A, Hoffman RM, Shah J.

Head Neck. 2002 May;24(5):437-42.

PMID:
12001073
19.

Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review.

Dohmen AJ, Swartz JE, Van Den Brekel MW, Willems SM, Spijker R, Neefjes J, Zuur CL.

Cancers (Basel). 2015 Aug 28;7(3):1716-42. doi: 10.3390/cancers7030858. Review.

20.

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.

Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87.

PMID:
15380569

Supplemental Content

Support Center